# FOAMIX PHARMACEUTICALS, INC. – FDA Inspection, Apr 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/foamix-pharmaceuticals-inc/448328a1-115c-4647-8f07-6e0789cb2aa7
Source feed: FDA_Inspections

> FDA inspection 1087253 of FOAMIX PHARMACEUTICALS, INC., April 24, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1087253
- Company Name: FOAMIX PHARMACEUTICALS, INC.
- Inspection Date: 2019-04-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/shirley-s-wen/eafbc8e5-a0ac-443a-adaf-ced505f77842)

Company: https://www.keypedia.com/companies/foamix-pharmaceuticals-inc/9912add0-b999-40e7-9fe5-60ded461ff2c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c